Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway
-
Published:2021-07
Issue:
Volume:87
Page:153575
-
ISSN:0944-7113
-
Container-title:Phytomedicine
-
language:en
-
Short-container-title:Phytomedicine
Author:
Yang Xue, Feng Ying, Liu Yao, Ye Xieqiong, Ji Xiaomin, Sun Le, Gao Fangyuan, Zhang Qun, Li Yuxin, Zhu BingbingORCID, Wang XianBo
Funder
University of Science and Technology Beijing Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support National Natural Science Foundation of China Beijing Outstanding Talent Training Foundation
Subject
Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine
Reference32 articles.
1. Chinese College of Interventionalists, C.M.D.A.J.-Z.g.z.b.z.z.Z.g.z.C.j.o.h., 2019. [Chinese Clinical Practice Guidelines for transarterial chemoembolization of hepatocellular carcinoma]. 2. p21 in cancer: intricate networks and multiple activities;Abbas;Nat. Rev. Cancer,2009 3. Addie, M., Ballard, P., Buttar, D., Crafter, C., Currie, G., Davies, B.R., Debreczeni, J., Dry, H., Dudley, P., Greenwood, R., Johnson, P.D., Kettle, J.G., Lane, C., Lamont, G., Leach, A., Luke, R.W.A., Morris, J., Ogilvie, D., Page, K., Pass, M., Pearson, S., Chemistry, L.R.J.-J.o.m., 2013. Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases. 4. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., Clinicians, A.J.J.-C.a.c.j.f., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 5. Galle, P.R., Tovoli, F., Foerster, F., Wörns, M.A., Cucchetti, A., Hepatology, L.B.J.-J.O., 2017. The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy.
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|